Eversept Partners, LP
Top Portfolio Positions
110 positions ·
$1,817,420,308 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
264,271 | $156,707,417 | 8.62% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
238,700 | $137,772,866 | 7.58% | |
| ABVX |
Abivax S.A.
Healthcare
|
934,423 | $104,048,001 | 5.73% | |
| GSK |
GSK plc
Healthcare
|
1,785,175 | $98,523,808 | 5.42% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
2,173,286 | $87,431,295 | 4.81% | |
| NTRA |
Natera, Inc.
Healthcare
|
384,713 | $76,938,752 | 4.23% | |
| SPY |
Spdr S&P 500 ETF Trust
|
107,000 | $69,586,380 | 3.83% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
2,885,622 | $67,408,129 | 3.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
1,788,016 | $56,715,867 | 3.12% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
924,193 | $53,704,855 | 2.96% |
Portfolio Trend
25 quarters · across all stocks
Holdings in UTHR
Shares Held
Position Value (USD)
26 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $156,707,417 | 264,271 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $123,075,452 | 252,592 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $106,152,356 | 253,220 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $6,791,202 | 16,200 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $17,058,820 | 59,366 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,722,134 | 57,489 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,420,166 | 43,703 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $46,925,574 | 130,949 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $74,971,061 | 235,351 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $57,690,732 | 251,135 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $54,144,394 | 246,234 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $60,511,250 | 267,903 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,482,858 | 260,398 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $49,743,083 | 222,107 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $64,735,736 | 232,787 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $53,439,219 | 255,226 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $73,244,923 | 310,834 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $52,429,701 | 292,234 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $1,642,208 | 7,600 | Call | Sole | 2023-11-08 | |
| 2021-12-31 | $84,686,073 | 391,920 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $82,040,457 | 444,471 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $79,468,762 | 442,945 | Shares | Sole | 2023-11-08 | |
| 2021-03-31 | $81,381,705 | 486,529 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $69,616,358 | 458,636 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $24,331,304 | 240,904 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $28,153,796 | 232,676 | Shares | Sole | 2023-11-08 | |
| No 13F history on record for this holder in this stock. | ||||||